Clinical trial
Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Individuals With an Acute Spinal Cord Injury - A Safety, Feasibility and Efficacy Study
NCT05731986 is registered in ClinicalTrials.gov with Kessler Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Individuals With an Acute Spinal Cord Injury - A Safety, Feasibility and Efficacy Study
- Lead sponsor
- Kessler Foundation
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 1, 2023
- Completion date
- August 31, 2026
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute spinal cord injury, blood pressure, cardiovascular diseases, central nervous system diseases, hypotension, nervous system diseases, orthostatic hypotension, spinal cord diseases, spinal cord injuries, trauma, nervous system